cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution.

cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution. Clin Cancer Res. 2022 05 02; 28(9):1841-1853.

View in: PubMed

subject areas

Biomarkers, Tumor
Cell-Free Nucleic Acids
Exome
Humans
Mutation
Neoplasm Recurrence, Local
Neoplasm, Residual
Neoplasms, Second Primary
Treatment Outcome

authors with profiles

Xiang Zhou